Why This Matters to Distributors: The $13 billion valuation Apollo placed on McKesson’s medical-surgical distribution unit confirms that scale distribution businesses with entrenched customer relationships in specialized markets command premium valuations — a dynamic reshaping ownership structures across industrial, healthcare and specialty distribution alike.
McKesson Corporation has signed a definitive agreement with funds managed by affiliates of Apollo under which Apollo will invest $1.25 billion in convertible preferred equity to acquire an approximately 13% minority interest in McKesson’s Medical-Surgical Solutions business, valuing the unit at $13 billion in total enterprise value.
McKesson will retain operating control and majority ownership of MMS and continue to consolidate its financial results. The transaction, subject to regulatory approvals and customary closing conditions, is the first major step in McKesson’s planned separation and initial public offering of MMS, which distributes medical supplies and equipment primarily to non-acute care settings including physician offices, surgery centers, and long-term care facilities.
“This transaction marks a key milestone in McKesson’s planned separation of MMS,” said Brian Tyler, chief executive officer of McKesson. “Apollo’s experience in supporting complex carve-out and public market transactions will be additive as we position MMS for success, while maintaining McKesson’s financial and strategic flexibility.”
Apollo partners Maxwell David and Jeff Armstrong framed the investment as a bet on the growth potential of healthcare supply chain infrastructure outside of hospitals. “MMS is a leading healthcare platform with a talented team and strong market position, playing a key role in healthcare supply chain resiliency across non-acute care settings,” they said in a statement.
The transaction reflects the increasing financialization of large-scale distribution assets — and the valuations those assets command when carved out of diversified parent companies. Apollo, which managed approximately $938 billion in assets as of Dec. 31, 2025, brings both the capital scale and transaction expertise to support a separation process that could culminate in a public offering.
The MMS business competes in a non-acute medical supply market that has drawn sustained interest from private equity and strategic acquirers as healthcare delivery shifts away from hospitals toward lower-cost outpatient and community-based settings. That structural shift has made dependable supply partners to physician offices, surgery centers, and long-term care operators increasingly valuable — and increasingly attractive to investors seeking durable distribution economics.
Do not miss any content from Distribution Strategy Group. Join our list.
Share this article:
